Diaspora Return Program: Turning Brain Drain into Social Capital
Design of a return-back program that turns brain drain into social capital.
The Signal
Turkey has a brain drain of approximately 17.9% in molecular biology and genetics and 10.2% in biomedical engineering. The standard reading considers this a loss. The more useful reading is that these people, embedded in the top biotech ecosystems of Boston, San Francisco, Basel, and Cambridge, are social capital that can't be bought. Israel Yozma, China Thousand Talents and Singapore Biopolis have proven that recalling this capital works. Türkiye has the pieces — Technology Visa, Terminal Istanbul, 0% R&D tax — but there is no program that combines them. The question is: will we continue to lose our most talented people, or will we turn them into a bridge?
Why It Matters
Emigration rates by discipline speak to more than ordinary “talent loss”: the highest loss in the highest value-added fields (molecular biology 17.9%, biomedical 10.2%). In contrast, the infrastructure pieces are ready: September 2024 Technology Visa, Terminal Istanbul, where Atatürk Airport has been transformed for more than 2,000 startups, and 0% corporate tax in technoparks until December 31, 2028. In May 2026, the Ministry of Industry announced a $300 million VC package; Total liquidity will exceed $750 million. There is capital and infrastructure; What is missing is the integrated offering that will attract returns.
0% R&D tax is real and scheduled. Corporate tax exemption for R&D and software income in technoparks is in effect until December 31, 2028; Personnel salary exemptions are also valid until the same date. These deadlines have been extended in the past, signals are in the direction of continuity - but the investment decision should be made according to the current calendar.
For public institutions (TÜBİTAK, YÖK): a pilot “Biotechnology Return Program” — $500,000–1,000,000 non-refundable grant + mentoring + 90-day regulatory fast track. For technoparks: offering the returning scientist a "works the day you land" setup (venue, administrative support, first team). For those targeting diaspora networks: physical launch in Boston/SF/Basel/Cambridge; because trust is built face to face, not email.
The Move
The most honest note: the obstacle to this opportunity is not technical, but macro. Political and economic instability overshadows even the most attractive financial stimulus; A scientist does not entrust his career to currency volatility. Second, the program will fail if designed as financial incentives alone — proven models have shown this over and over again. Third, the return is not a scalable “production”; Every case is personal and requires patience and continuity. So this is not a quick win, but a perennial ecosystem building — but if the seed is not planted today, it will never germinate.
* Preliminary meeting with TÜBİTAK and YÖK for the "Biotechnology Return Program" concept. 2. Pilot draft: $500,000–$1,000,000 grant + mentoring + 90-day fast track. 3. Starting a pilot with 2–3 diaspora scientists. 4. Program scaling plan; Boston/SF/Basel/Cambridge promotion. 5. Embody the promise of a “professional ecosystem” beyond financial incentive — that's the difference.
Read the Full Analysis
For the full original analysis, read the Ghost version here: https://www.mesutaydin.link/ceo-brifingi-05-diaspora-geri-donus-programi-beyin-gocunu-sosyal-sermayeye-cevirmek/
This article is for strategic information only. It is not legal, investment, or tax advice.